VIVE (Viveve Medical) Current Accrued Expense: $3.44 Mil (As of Sep. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VIVE Viveve Medical Inc VIVE
12 GF Score
Price $0.00
View Full Analysis

What is Viveve Medical Current Accrued Expense?

Viveve Medical VIVE 12 Current Accrued Expense is $3.44 Mil as of Sep. 2022. GuruFocus rates VIVE with a GF Score™ of 12/100.

Viveve Medical's Current Accrued Expense for the quarter that ended in Sep. 2022 was $3.44 Mil.

Viveve Medical's quarterly Current Accrued Expense increased from Mar. 2022 ($2.64 Mil) to Jun. 2022 ($2.95 Mil) and increased from Jun. 2022 ($2.95 Mil) to Sep. 2022 ($3.44 Mil).

Viveve Medical's annual Current Accrued Expense declined from Dec. 2019 ($3.61 Mil) to Dec. 2020 ($1.94 Mil) but then increased from Dec. 2020 ($1.94 Mil) to Dec. 2021 ($2.38 Mil).

Viveve Medical Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Viveve Medical's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viveve Medical Current Accrued Expense Chart

Viveve Medical Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.46 6.08 3.61 1.94 2.38

Viveve Medical Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.91 2.38 2.64 2.95 3.44
VIVE
12GF Score
Viveve Medical Inc VIVE
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viveve Medical Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $3.44 Mil mean?
Viveve Medical (VIVE) has a Current Accrued Expense of $3.44 Mil as of Sep. 2022. Current Accrued Expense records the total amount of accrued expenses. View historical data on Viveve Medical and its competitors.
Is Viveve Medical's Current Accrued Expense too high?
Viveve Medical's current Current Accrued Expense is $3.44 Mil. Overall, Viveve Medical has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Viveve Medical's Current Accrued Expense compare to NNMX and LHDXQ?
Viveve Medical's Current Accrued Expense of $3.44 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Devices & Instruments company?
A good Current Accrued Expense depends on the Medical Devices & Instruments industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Viveve Medical and its competitors. Viveve Medical's current Current Accrued Expense is $3.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viveve Medical stock overvalued right now?
Viveve Medical (VIVE) has a current Current Accrued Expense of $3.44 Mil. The current Current Accrued Expense is $3.44 Mil. Viveve Medical's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Viveve Medical (VIVE), the current Current Accrued Expense is $3.44 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Viveve Medical Business Description

Address 345 Inverness Drive South, Building B, Suite 250, Englewood, CO, USA, 80112
Viveve Medical Inc designs, develops, manufactures and markets a platform medical technology. Its Cryogen-cooled Monopolar Radiofrequency technology is delivered through a radiofrequency generator, handpiece and treatment tip, called the Viveve System. The Viveve System is for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The Viveve System is indicated for use and being marketed for use in general surgical procedures for electrocoagulation and hemostasis in the United States. It has a business presence in the US, Asia Pacific, Canada, Europe and Middle East and Latin America.
12GF Score

Get the complete analysis for VIVE

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price